Virinchi touches the roof on its arm collaborating with MedGenome for Molecular Diagnostics

22 Nov 2017 Evaluate

Virinchi is currently trading at its upper circuit limit of Rs. 108.85, up by 5.15 points or 4.97% from its previous closing of Rs. 103.70 on the BSE.

The scrip opened at Rs. 108.50 and has touched a high and low of Rs. 108.85 and Rs. 105.10 respectively. So far 85878 shares were traded on the counter.

The BSE group 'XC' stock of face value Rs. 10 has touched a 52 week high of Rs. 131.50 on 10-Apr-2017 and a 52 week low of Rs. 54.50 on 22-Nov-2016.

Last one week high and low of the scrip stood at Rs. 108.85 and Rs. 85.10 respectively. The current market cap of the company is Rs. 286.95 crore.

The promoters holding in the company stood at 50.06%, while Institutions and Non-Institutions held 0.26% and 49.67% respectively.

Virinchi’s 100% subsidiary - Virinchi Hospitals has entered into a strategic collaboration with MedGenome, a genomics based Diagnostics and Research Company towards offering a range of diagnostic tests to its patients specifically in the field of cardiology, ophthalmology, oncology, neurology, nephrology, diabetes, dermatology, haematology, connective tissue and metabolic disorders to their patients. This strategic partnership opens doors to better diagnosis, advanced treatment and innovative research avenues for Virinchi Hospitals.

Virinchi is an IT Products & Services company listed on Bombay Stock Exchange (BSE), India, focusing on customers in North America, Europe, & Middle East.

Virinchi Share Price

22.27 -0.30 (-1.33%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
TCS 3238.90
Infosys 1615.95
HCL Tech. 1682.85
Wipro 260.00
Tech Mahindra 1569.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×